We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Trend Four: Drug Manufacturers Need a Culture of Compliance
Trend Four: Drug Manufacturers Need a Culture of Compliance
August 8, 2012
In assessing violations and determining the need for warning letters, the FDA is also paying increased attention to a company’s internal corporate compliance program.